Clin2
NCT07693166Possibly a fitNot yet recruiting

RSV vaccine study for pregnant women with HIV

RSV ImmunizationHIV

Treatments studied

Part of Immune system & allergy, Infections, Women’s health & pregnancy clinical trials.

This trial tests if the RSVpreF vaccine given during pregnancy can help pass antibodies to the baby in women living with HIV. It may protect the infant from RSV, a common respiratory virus.

Summary written for real people, not researchers, by Clin2.

Phase
Phase 4
Enrollment
20 people
Ages
19 years and older
Study type
Interventional

Who can take part

  • You are pregnant and have HIV.
  • You are 19 years or older.
  • You are between 28 and 34 weeks pregnant when you join.
  • You can get the vaccine between 32 and 36 weeks of pregnancy.
  • You are willing to have your baby followed up at the Oak Tree Clinic in British Columbia.

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT07041190Not yet recruiting· Phase 3
RSV Prevention Trial for Pregnant Women and Newborns

This trial tests two ways to protect babies from RSV: a vaccine given to pregnant women, and an antibody shot given to newborns. Both are already approved—this study checks if using them together works better than either alone.

NCT07232706Recruiting· Phase 3
RSV prevention in infants with nirsevimab and maternal vaccine

This trial tests giving a medicine called nirsevimab to newborns and a possible vaccine to pregnant mothers to prevent RSV, a serious lung infection in babies. It checks if combining both is safe and works better than nirsevimab alone.

La Roche-sur-Yon
NCT07296120Not yet recruiting· Phase 4
RSV vaccine study for stem cell and CAR-T therapy patients

This trial tests how well the RSV vaccine works in people who have had a stem cell transplant or CAR-T therapy for blood cancer. It will help understand if the vaccine protects you against RSV, a common respiratory virus.

Camden, New Jersey
NCT06955728Recruiting· Phase 3
RSV vaccine in pregnancy to protect babies

This study tests an approved RSV vaccine given to pregnant women. The goal is to see if it safely protects their babies from severe RSV lung infections during the first months of life.

Kintampo, Bono East
NCT06521944Recruiting
RSV vaccine safety registry for pregnant people

This registry follows pregnant people who received an RSV vaccine during a specific window (32 to 36 weeks) to monitor safety. If you got the shot in that time, your information helps researchers understand how well the vaccine works in pregnancy.

Wilmington, North Carolina
NCT06866405Recruiting· Phase 3
RSV vaccine boost in a new pregnancy

This study tests whether a second dose of the RSV vaccine during a new pregnancy protects you and your baby from RSV. If you received the RSVpreF or Abrysvo vaccine in a past pregnancy, you may be able to join.

Birmingham, Alabama

Hear when a new RSV Immunization trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.